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Objectives: The Short-Form 36 Health Survey version 2.0 (SF-36v2®) is a validated 
patient-reported outcome instrument. A validated single-item format version exists 
for deployment on computer screens/tablet-sized devices, and an electronic hand-
held version was developed in 2012. The objectives of this study were to evaluate 
measurement equivalence between the paper and electronic versions of the SF-36v2 
administered using a handheld device or a smartphone app, and to determine 
patient preference for mode of administration. MethOds: This was a randomized 
crossover study in which 101 subjects with type II diabetes completed the SF-36v2 
on two modalities: paper and either the electronic handheld (PHT LogPad® LW) 
or the smartphone App (PHT LogPad App). Subjects completed the assessment in 
a single session with distraction activities between completion of the first and 
second modality and an exit survey which assessed patient preference for mode of 
administration. Results: Study data will be analyzed to test score level equivalence 
and to calculate the intraclass correlation coefficient (ICC) and other measures of 
measurement equivalence. Equivalence analysis is in progress, and findings will 
be ready to present for this meeting. 82% of subjects found the electronic method 
easy to use and 80% found it easy to navigate. Of those subjects who expressed a 
preference, 57% found it more physically comfortable and 69% found it faster to 
complete than paper. 65% would prefer the electronic method over paper when 
responding to questions in a clinical trial. cOnclusiOns: This study will evaluate 
the measurement equivalence between standard paper versions of the SF-36v2 
and electronic handheld versions as deployed on an electronic handheld device or 
a smartphone App. Patients with diabetes generally prefer to complete the SF-36v2 
electronically rather than on paper.
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Objectives: Angiotensin-converting enzyme inhibitors (ACEI) have been impli-
cated in bradykinin-mediated angioedema. With ever-widening indications for 
ACEI including hypertension, congestive heart failure, diabetic nephropathy, 
etc., a concomitant increase in ACEI-Angioedema (ACEI-A) has been reported. 
At present there is no validated severity scoring or discharge criteria for ACEI-A. 
We sought to develop an investigator rating scale with corresponding discharge 
criteria. This study aimed to confirm the clinical relevance, content validity, and 
reliability of the scale with clinicians experienced in treating ACEI-A. MethOds: 
In-depth, 60-minute qualitative telephone interviews were conducted with 12 
US-based emergency physicians. Beforehand, clinicians were sent four case stud-
ies describing patients experiencing different severities of angioedema attacks. 
Clinicians were initially asked open-ended questions about their experience of 
patients’ symptoms, treatment and discharge decisions. Clinicians then rated 
each patient case study and discussed patient diagnoses, ratings of symptom 
severity and discharge evaluation. The ratings were used to assess inter-rater 
reliability of the scale using the intra-class correlation coefficient (ICC) using IBM 
SPSS analysis Version 19 software. Results: The findings provide support for 
focus on the four key symptoms of airway compromise scored on a 0-4 scale: 
1) Difficulty Breathing, 2) Difficulty Swallowing, 3) Voice Changes and 4) Tongue 
Swelling and the corresponding discharge criteria of a score of 0 or ‘No symptoms’ 
for Difficulty Breathing and Difficulty Swallowing and a score of 0 or 1 indicat-
ing mild or absence of symptoms for Voice Change and Tongue Swelling. Eleven 
clinicians agreed the absence of standardized discharge criteria supported the 
use of the scale and all physicians concurred with the recommended discharge 
criteria. The clinician ratings provided evidence of strong inter-rater reliability 
for the rating scale (ICC> 0.80). cOnclusiOns: The investigator rating scale and 
discharge criteria are clinically valid, relevant and reliable. Moreover, both address 
the current unmet need for standardized discharge criteria.
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Objectives: sIBM is a progressive idiopathic inflammatory myopathy characterized 
by the asymmetric atrophy and weakness of proximal and distal muscle groups. 
Atrophy of the quadriceps, wrist, and finger flexor muscles and dysphagic pro-
cesses are clinical hallmarks and result in significant functional disabilities with 
progression. To understand impact on patients, a qualitative study was conducted to 
support the development of a disease model depicting relationships among patient 
concepts relevant to disease progression that may be impacted by the treatment of 
sIBM. No such disease model is currently available. MethOds: A literature review 
was conducted to determine a preliminary understanding of the impact of sIBM. 
This was followed by therapeutic area expert input and interviews of patients diag-
nosed with sIBM (n = 20). Based on all results, a model was constructed. Results: 
Results from literature and expert input allowed for the development of an initial 
diagram depicting a proposed pathway from a diagnosis of sIBM, modifying factors 
(e.g. age, gender, duration, severity, falls), proximal concepts of signs and symptoms 
of disease (weakness, atrophy), functioning (upper extremity, lower extremity, gen-
eral, swallowing) and through more distal psychosocial concepts (emotions, mood, 
relationships). Patient feedback was used to further refine the model. Some physical 
1) to fill in the questionnaire online, focusing on the instructions developed for 
online use; 2) to comment on their understanding of the instructions and suggest 
alternative formulations in case of problematic wording; and 3) to comment on 
the online administration and handiness of the version on the device (i.e., leg-
ibility of the instructions and items/response choices). After the test session, the 
interviewer asked questions about easiness of completion, navigation, instruc-
tions, screen and font size, and also reported on any hesitations or questions 
asked by the patient during the process. The severity of the issues encountered 
during the test was divided into three levels with level 1 indicating inability of 
use and/or incomprehensibility of instructions. Results: All respondents were 
able to answer the questions on their own without help. The respondents found 
the instructions very clear, and completing the online versions of the instruments 
proved to be easy and quick. For those who wished to correct their answers, going 
back to the previous screens was also easy. Minor changes were suggested to the 
screen resolution, font size of the response choices of the AQLQ(S)+12, and to 
the background colour. It was also suggested the number of questions should be 
included on the first screen. The online versions were revised accordingly. All par-
ties involved agreed that there was no need for further testing. cOnclusiOns: 
The web-based UK versions of the AQLQ(S)+12 and (ACQ-6) proved to be easy to 
use and understandable with minor improvements.
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Objectives: To demonstrate how patient and parent/legal guardian interviews 
reinforce a conceptual model of pediatric functional constipation signs, symp-
toms, and impact for inclusion in a Pediatric Functional Constipation Daily Diary 
(PFC-DD); and to evaluate patient and parent/legal guardian comprehension and 
usability of the PFC-DD administered via electronic diary. MethOds: Qualitative 
patient interviews were conducted with pediatric patients who have functional 
constipation and their parent/legal guardian to determine the most important 
and relevant signs, symptoms, and impacts associated with the condition, and 
to evaluate comprehension and usability of the draft PFC-DD. Concept elicitation 
(CE) and cognitive interviews (CI) were conducted with the parent/legal guardian 
of children ages 6 months to < 6 years (CE, n= 18; CI, n= 11), and with children/
adolescents ages 6 to < 18 years and their parent/legal guardian (CE, n= 18; CI 
patient n= 21, parent n= 20). Results: For both groups, the predominant sign/
symptom concepts reported were: stool consistency changes, toileting avoidance 
and/or retentive posturing, child report and/or behaviors suggesting abdominal 
pain, difficulty while toileting (e.g., straining, rectal pain), infrequent bowel move-
ments, and appetite changes. Parents of children ages 6 months to < 6 years also 
reported abdominal hardness, gas, and soiling. The predominant impacts reported 
were limitations in physical activity, emotional and social function, sleep (younger 
age group only), school participation (older age group only), and coping strategies 
(e.g., medications/supplements). Results from the CIs indicated no comprehension 
problems for most items. However, minor revisions (e.g., definition for ‘reten-
tive posturing’) were made to the wording of a few items to improve clarity and 
appropriate understanding of the concept. No concerns were raised about the 
usability of the electronic diary. cOnclusiOns: Findings support the content 
validity of the PFC-DD, a new instrument that includes PRO and ObsRO items to 
assess the key signs, symptoms, and impacts experienced by pediatric patients 
with functional constipation.
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Objectives: (1) To identify the translation issues during linguistic validation of 
a behavioural scale, (2) to ascertain whether the same issues appeared in more 
than one language, (3) to determine what solutions were found to ensure con-
ceptual accuracy, with a view to collecting consistently valid data across the 
study. MethOds: 28 back translation and psychologist reviews of a behavioural 
scale were examined, in which translation issues had been discussed at length 
between lead translators, project managers and experts in the field. Information 
was gathered on the translation difficulties that arose in each language and the 
results were compared in order to identify patterns. Results: Three main cat-
egories of discussion were identified: Transferral of word length and complexity 
was particularly important. Literal translations needed replacing with culturally 
adapted wording across a high percentage of the languages to ensure overall 
conceptual equivalence. Many idioms and common phrases were found to be non-
sensical when translated literally. Across all languages, expressions like ‘Button 
your lip’ and ‘Hit the road’ were replaced with localised sayings that would enable 
conceptual comprehension of the items. Questions regarding grammar and tense 
led to alterations and omissions in a number of languages due to dramatic dif-
ferences in language structure across the world. In questions regarding irregular 
verb use, for example, most languages replaced the examples or removed them 
altogether if no such irregular verbs existed. cOnclusiOns: The behavioural 
scale was found to contain many translation issues arising from its focus on 
language specific distinctions. Patterns were found in the resolution of these 
issues and changes often necessitated moving away from a literal translation 
so that concepts and ideas could be appropriately conveyed. This highlights the 
importance of linguistic validation and its ability to improve translation quality 
for cross-cultural comparison.
